Building world leading surgical oncology for gastric cancer in China.
10.3760/cma.j.cn112139-20221014-00437
- Author:
Zhe Min LI
1
;
Zi Yu LI
1
;
Jia Fu JI
1
Author Information
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Stomach Neoplasms/surgery*;
Surgical Oncology;
Artificial Intelligence;
Gastrectomy;
China/epidemiology*;
Minimally Invasive Surgical Procedures
- From:
Chinese Journal of Surgery
2023;61(1):18-22
- CountryChina
- Language:Chinese
-
Abstract:
This century has seen significant advances in the treatment and research of gastric cancer in China. Chinese scholars have made a series of key technological breakthroughs in minimally invasive surgery, perioperative treatment and artificial intelligence diagnosis. These world-leading clinical researches have improved treatment outcomes and reduced surgical trauma. Global surveillance of trends in cancer survival 2000-14 reported that survival of gastric cancer in China has significantly improved during the last 20 years. This paper reviews the research history of surgical oncology for gastric cancer in China, summarises the experience and attempts to explore the future direction.
